Beltran Pedro 4
4 · BridgeBio Oncology Therapeutics, Inc. · Filed May 5, 2026
Insider Transaction Report
Form 4
Beltran Pedro
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
[F1]2026-04-01$9.03/sh−1,047$9,454→ 45,623 total
Footnotes (1)
- [F1]Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
Signature
/s/ Aaron Chan, Attorney-in-Fact|2026-05-05